Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Cobas ® EGFR Mutation Test v2 Assay

3 Feb 2016

Abstract excerpt

Paul Brown speaks to Gemma Westcott, Commissioning Editor: Paul Brown has served as the Head of Roche Molecular Diagnostics at Roche Diagnostics Corporation since February 2010 having previously held a variety of positions within Roche Pharma. After completing his doctorate in organic chemistry he was awarded a post-doctoral fellowship at the California Institute of Technology in Pasadena, CA, USA, but soon...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26838018
DOI: 10.2217/fon.15.311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Cobas ® EGFR Mutation Test v2 AssayPMID 26838018Read ↗

A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancerSemantic proximity Read ↗

A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection tests.Semantic proximity Read ↗

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.Semantic proximity Read ↗

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutationsSemantic proximity Read ↗

Comparison of next-generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.Semantic proximity Read ↗

ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor Mutation Testing in PracticeSemantic proximity Read ↗

Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation.Semantic proximity Read ↗

[EGFR testing: state of organizations in France in 2010].Semantic proximity Read ↗

Rapid screening for EGFR mutations: pros and cons.Semantic proximity Read ↗

[Epidermal growth factor receptor mutation detection methods: a general review].Semantic proximity Read ↗

Predictive tests for EGFR inhibitors.Semantic proximity Read ↗

[An assay for the rapid detection of EGFR and KRAS gene mutation in cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.